These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35378894)
1. A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by Chen Y; Ying S; Jiang L; Dong S; Dai J; Jin X; Yu W; Qiu Y Infect Drug Resist; 2022; 15():1317-1328. PubMed ID: 35378894 [TBL] [Abstract][Full Text] [Related]
2. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China. Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221 [TBL] [Abstract][Full Text] [Related]
3. Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019. Li M; Yang S; Yao H; Liu Y; Du M Infect Dis Ther; 2023 Feb; 12(2):473-485. PubMed ID: 36520329 [TBL] [Abstract][Full Text] [Related]
4. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study. Chen Y; Chen Y; Liu P; Guo P; Wu Z; Peng Y; Deng J; Kong Y; Cui Y; Liao K; Huang B BMC Geriatr; 2022 Jul; 22(1):573. PubMed ID: 35831805 [TBL] [Abstract][Full Text] [Related]
5. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China. Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222 [TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Zheng X; Wang JF; Xu WL; Xu J; Hu J Antimicrob Resist Infect Control; 2017; 6():102. PubMed ID: 29026535 [TBL] [Abstract][Full Text] [Related]
8. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients. Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for a Hospital-Acquired Carbapenem-Resistant Cao Z; Yue C; Kong Q; Liu Y; Li J Infect Drug Resist; 2022; 15():641-654. PubMed ID: 35241916 [TBL] [Abstract][Full Text] [Related]
10. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423 [TBL] [Abstract][Full Text] [Related]
11. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China. Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing. Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112 [TBL] [Abstract][Full Text] [Related]
13. Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Liang X; Chen P; Deng B; Sun FH; Yang Y; Yang Y; He R; Qin M; Wu Y; Yang F; Tian GB; Dai M Infect Drug Resist; 2022; 15():3161-3171. PubMed ID: 35747334 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Risk Factors for Carbapenem Resistant Wang H; Tian F; Wang X; Zhao M; Gao R; Cui X Infect Drug Resist; 2023; 16():7351-7363. PubMed ID: 38050629 [TBL] [Abstract][Full Text] [Related]
15. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019. Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Risk Factors and Mortality of Patients with Carbapenem-Resistant Wu C; Zheng L; Yao J Infect Drug Resist; 2022; 15():2383-2391. PubMed ID: 35535031 [TBL] [Abstract][Full Text] [Related]
17. Mortality associated with carbapenem resistance in Wang L; Zeng C; Li X; Li Y; Liu Z; Hu J Infect Control Hosp Epidemiol; 2024 Jul; 45(7):839-846. PubMed ID: 38487826 [TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M; Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072 [TBL] [Abstract][Full Text] [Related]
19. The Value of Neutrophil-To-Lymphocyte Ratio for Evaluating Blood Stream Infection Caused by Carbapenem-Resistant Wu H; Mao Y; Du X; Zhao F; Jiang Y; Yu Y Front Med (Lausanne); 2022; 9():832655. PubMed ID: 35345766 [TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Carbapenem-resistant Wang Z; Qin RR; Huang L; Sun LY Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]